title: Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
source: Yahoo
date: 2025-10-13
url: https://finnhub.io/api/news?id=1900b88e6a2a50638917eb0b5c9eb8c7adc6e9a74f526f9292dc73907ddd72d1
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced the appointment of Sue Hohenleitner as Chief Financial Officer (CFO), effective November 4, 2025. Ms. Hohenleitner is a proven financial leader, bringing more than 30 years of experience in corporate finance, strategic planning, inves
